A Phase I Study Of SU5416 With Androgen Ablation And Radiation In Patients With Intermediate and Advanced Stage Prostate Cancer.
Latest Information Update: 18 Sep 2021
At a glance
- Drugs Semaxanib (Primary) ; Bicalutamide; Flutamide; Goserelin; Leuprorelin
- Indications Prostate cancer
- Focus Adverse reactions
Most Recent Events
- 05 Sep 2013 Biomarkers information updated
- 20 Nov 2010 New trial record